Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group

J. H. Schiller*, S. Adak, D. Cella, R. F. DeVore, D. H. Johnson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

266 Scopus citations

Fingerprint

Dive into the research topics of 'Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science